Compuestos orgánicos

Mesilato de casmostato, o un solvato del mismo, para el tratamiento de fibrosis quística. The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the tre...

Full description

Saved in:
Bibliographic Details
Main Authors SINGH, DILRAJ, MAAS, JANET C, TULLY, DAVID, MONNIER, STEPHANIE, HEUERDING, SILVIA, REBER, JEAN-LOUIS, HARRIS, JENNIFER, ROETTELE, JUERGEN, DANAHAY, HENRY L, LEGRAND, DARREN M
Format Patent
LanguageSpanish
Published 17.10.2012
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Mesilato de casmostato, o un solvato del mismo, para el tratamiento de fibrosis quística. The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
AbstractList Mesilato de casmostato, o un solvato del mismo, para el tratamiento de fibrosis quística. The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Author REBER, JEAN-LOUIS
TULLY, DAVID
ROETTELE, JUERGEN
DANAHAY, HENRY L
LEGRAND, DARREN M
HEUERDING, SILVIA
MONNIER, STEPHANIE
HARRIS, JENNIFER
SINGH, DILRAJ
MAAS, JANET C
Author_xml – fullname: SINGH, DILRAJ
– fullname: MAAS, JANET C
– fullname: TULLY, DAVID
– fullname: MONNIER, STEPHANIE
– fullname: HEUERDING, SILVIA
– fullname: REBER, JEAN-LOUIS
– fullname: HARRIS, JENNIFER
– fullname: ROETTELE, JUERGEN
– fullname: DANAHAY, HENRY L
– fullname: LEGRAND, DARREN M
BookMark eNrjYmDJy89L5WQQdc7PLShNLS7JL1bIL0o_vDAvMzm_mIeBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxLsGGxlbWJhZGIeEGBsTowYApx8kYg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ES2388683TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_ES2388683TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 15:36:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ES2388683TT33
Notes Application Number: ES20060742574T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121017&DB=EPODOC&CC=ES&NR=2388683T3
ParticipantIDs epo_espacenet_ES2388683TT3
PublicationCentury 2000
PublicationDate 20121017
PublicationDateYYYYMMDD 2012-10-17
PublicationDate_xml – month: 10
  year: 2012
  text: 20121017
  day: 17
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies IRM LLC
NOVARTIS PHARMA GMBH
NOVARTIS AG
IRM, LLC
RelatedCompanies_xml – name: IRM LLC
– name: NOVARTIS PHARMA GMBH
– name: NOVARTIS AG
– name: IRM, LLC
Score 2.737052
Snippet Mesilato de casmostato, o un solvato del mismo, para el tratamiento de fibrosis quística. The invention describes novel pharmaceutically acceptable salt forms...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Compuestos orgánicos
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20121017&DB=EPODOC&locale=&CC=ES&NR=2388683T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTcwSjZMSzTTtTBJTNU1STQ31LVMMkjWTUk2MklKM7UE3XMCWm3hZ-YRauIVYRrBxJAJ2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9Y9BpWIbmai5Otq4B_i7-zmrOzrbARpVfkC2wZrIwszAOMWZmYAW1okHH7LuGOYE2pRQg1yhuggxsAUDD8kqEGJhSi4UZOJ1hF68JM3D4Que7gUxo1isWYRAF378AugemWCG_KP3wwjxgHBaLMii6uYY4e-gCzY-H-yXeNRjmkhBjYzEGFmAfP1WCQSElKSU5ydIk0cg4xdjExCAp0czYINnI0iwpzdjSIC3RWJJBCrc5UvgkpRm4QOECKm4NzWUYWEqKSlNlgfVoSZIcOAQATtN34w
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTcwSjZMSzTTtTBJTNU1STQ31LVMMkjWTUk2MklKM7UE3XMCWm3hZ-YRauIVYRrBxJAJ2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1KC9Y9BpWIbmai5Otq4B_i7-zmrOzrbARpVfkC2wZrIwszAOMWZmYDUHHc4LajmFOYE2pRQg1yhuggxsAUDD8kqEGJhSi4UZOJ1hF68JM3D4Que7gUxo1isWYRAF378AugemWCG_KP3wwjxgHBaLMii6uYY4e-gCzY-H-yXeNRjmkhBjYzEGFmAfP1WCQSElKSU5ydIk0cg4xdjExCAp0czYINnI0iwpzdjSIC3RWJJBCrc5Uvgk5Rk4PUJ8feJ9PP28pRm4QGEEKnoNzWUYWEqKSlNlgXVqSZIcODQAEgR60A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Compuestos+org%C3%A1nicos&rft.inventor=SINGH%2C+DILRAJ&rft.inventor=MAAS%2C+JANET+C&rft.inventor=TULLY%2C+DAVID&rft.inventor=MONNIER%2C+STEPHANIE&rft.inventor=HEUERDING%2C+SILVIA&rft.inventor=REBER%2C+JEAN-LOUIS&rft.inventor=HARRIS%2C+JENNIFER&rft.inventor=ROETTELE%2C+JUERGEN&rft.inventor=DANAHAY%2C+HENRY+L&rft.inventor=LEGRAND%2C+DARREN+M&rft.date=2012-10-17&rft.externalDBID=T3&rft.externalDocID=ES2388683TT3